Article Versions Notes

Habermann F-NOJ, Schmitt D, Failing T, Ziegler DA, Fischer J, Fischer LA, Guhlich M, Bendrich S, Knaus O, Overbeck TR, et al. And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept. Cancers. 2024; 16(1):231. https://doi.org/10.3390/cancers16010231

Habermann, Felix-Nikolai Oschinka Jegor, Daniela Schmitt, Thomas Failing, David Alexander Ziegler, Jann Fischer, Laura Anna Fischer, Manuel Guhlich, Stephanie Bendrich, Olga Knaus, Tobias Raphael Overbeck, and et al. 2024. "And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept" Cancers 16, no. 1: 231. https://doi.org/10.3390/cancers16010231

Habermann, F.-N. O. J., Schmitt, D., Failing, T., Ziegler, D. A., Fischer, J., Fischer, L. A., Guhlich, M., Bendrich, S., Knaus, O., Overbeck, T. R., Treiber, H., von Hammerstein-Equord, A., Koch, R., El Shafie, R., Rieken, S., Leu, M., & Dröge, L. H. (2024). And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept. Cancers, 16(1), 231. https://doi.org/10.3390/cancers16010231